Teleflex/$TFX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Teleflex
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Ticker
$TFX
Sector
Primary listing
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Employees
14,100
ISIN
US8793691069
Website
Teleflex Metrics
BasicAdvanced
$5B
35.51
$3.20
1.08
$1.36
1.20%
Price and volume
Market cap
$5B
Beta
1.08
52-week high
$245.46
52-week low
$112.32
Average daily volume
532K
Dividend rate
$1.36
Financial strength
Current ratio
2.277
Quick ratio
1.108
Long term debt to equity
46.518
Total debt to equity
48.96
Dividend payout ratio (TTM)
41.99%
Interest coverage (TTM)
7.14%
Profitability
EBITDA (TTM)
842.883
Gross margin (TTM)
55.98%
Net profit margin (TTM)
4.96%
Operating margin (TTM)
18.82%
Effective tax rate (TTM)
28.88%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
4.84%
Return on equity (TTM)
3.48%
Valuation
Price to earnings (TTM)
35.513
Price to revenue (TTM)
1.755
Price to book
1.24
Price to tangible book (TTM)
-6.48
Price to free cash flow (TTM)
11.011
Free cash flow yield (TTM)
9.08%
Free cash flow per share (TTM)
1,031.57%
Dividend yield (TTM)
1.20%
Forward dividend yield
1.20%
Growth
Revenue change (TTM)
0.29%
Earnings per share change (TTM)
-48.69%
3-year revenue growth (CAGR)
2.23%
10-year revenue growth (CAGR)
5.16%
3-year earnings per share growth (CAGR)
-32.24%
10-year earnings per share growth (CAGR)
-2.41%
What the Analysts think about Teleflex
Analyst ratings (Buy, Hold, Sell) for Teleflex stock.
Bulls say / Bears say
Teleflex reported a 2.4% increase in third-quarter revenue to $764.4 million, driven by strong demand for its medical devices, particularly in the vascular access segment, which saw sales rise by 6.5% to $180.9 million. (reuters.com)
The company raised its 2024 adjusted profit forecast to between $13.80 and $14.20 per share, up from the previous outlook of $13.60 to $13.95, reflecting confidence in sustained demand for surgical procedures utilizing its devices. (reuters.com)
Teleflex completed the acquisition of Palette Life Sciences for $594.9 million, aiming to expand its product offerings and market reach, which could drive future revenue growth. (secsense.ai)
In the first quarter of 2025, Teleflex reported a 5.0% decline in revenue to $700.7 million compared to the same period in 2024, indicating potential challenges in maintaining growth momentum. (santelog.com)
The company recognized a $240 million goodwill impairment charge in its Interventional Urology segment, primarily due to a prolonged period of subdued revenue growth and increased competitive pressures. (secsense.ai)
Teleflex's debt-to-equity ratio stands at 47.1%, with total debt of $1.9 billion, which may raise concerns about the company's leverage and financial flexibility. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
Teleflex Financial Performance
Revenues and expenses
Teleflex Earnings Performance
Company profitability
Teleflex News
AllArticlesVideos
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
GlobeNewsWire·1 day ago
Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business
GlobeNewsWire·2 weeks ago
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Teleflex stock?
Teleflex (TFX) has a market cap of $5B as of July 18, 2025.
What is the P/E ratio for Teleflex stock?
The price to earnings (P/E) ratio for Teleflex (TFX) stock is 35.51 as of July 18, 2025.
Does Teleflex stock pay dividends?
Yes, the Teleflex (TFX) stock pays dividends to shareholders. As of July 18, 2025, the dividend rate is $1.36 and the yield is 1.2%. Teleflex has a payout ratio of 41.99% on a trailing twelve-month basis.
When is the next Teleflex dividend payment date?
The next Teleflex (TFX) dividend payment date is unconfirmed.
What is the beta indicator for Teleflex?
Teleflex (TFX) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.